TRV-120027 TFA
Ref. TM-TP2158
| 1mg | 69.00 € | ||
| 5mg | 184.00 € | ||
| 10mg | 293.00 € | ||
| 25mg | 503.00 € | ||
| 50mg | 726.00 € | ||
| 100mg | 993.00 € | ||
| 1ml*10 (DMSO) | 334.00 € |
Estimated delivery in United States, on Tuesday 14 May 2024
Product Information
Name:
TRV-120027 TFA
Synonyms:
- TRV-120027 TFA (1234510-46-3 free base)
Description:
TRV-120027 TFA is an angiotensin II-mediated vasoconstriction inhibitor and increases cardiomyocyte contractility. TRV-120027 TFA is a β-arrestin-1-biased AT1R agonist engaging ß-arrestins while blocking G-protein signaling[1]. TRV-120027 TFA induces acute catecholamine secretion through cation channel subfamily C3 (TRPC3) coupling and promotes the formation of a macromolecular complex composed of AT1R-β-arrestin-1-TRPC3-PLCγ at the plasma membrane.
Brand:
Targetmol
Long term storage:
Notes:
Chemical properties
Molecular weight:
1040.1
Formula:
C45H68F3N13O12
Purity:
97.45%
Color/Form:
Solid
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:
Technical inquiry about: TM-TP2158 TRV-120027 TFA
Please use instead the cart to request a quotation or an order
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
